KIT and ovarian cancer: CD117+ ovarian cancer cells exhibit properties unique to CSC/TICs; these properties are associated with self-renewal, high tumorigenic potential, differentiation and chemoresistance of CD117+ cells sorted from established mouse xenograft using human ovarian serous adenocarcinoma [24].